Evidence map›Paper›PMID 41814200›Full record

ArticleBMC infectious diseases2026

Parametric Bayesian modelling of tuberculosis mortality determinants and facility level heterogeneity effect using Gamma and Gaussian shared frailty techniques.

Jacques L Tamuzi, Isaac Fwemba, Veranyuy D Ngah, Motlatsi Rangoanana, Llang Maama, Sele Maphalale, Mabatho Molete, Retselisitsoe Ratikoane, Modupe Ogunrombi, Olawande Daramola and 3 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jacques L Tamuzi *Division of Epidemiology and Biostatistics, Faculty of Medicine, and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Isaac Fwemba *Department of Epidemiology and Biostatistics, School of Public Health, University of Zambia, Lusaka, Zambia.
Veranyuy D NgahDivision of Epidemiology and Biostatistics, Faculty of Medicine, and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Motlatsi RangoananaDivision of Epidemiology and Biostatistics, Faculty of Medicine, and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Llang MaamaDisease Control Directorate, Ministry of Health Lesotho, National Tuberculosis Program, Ministry of Health, Maseru, Lesotho.
Sele MaphalaleDistrict Health Management Team, Butha Buthe, Ministry of Health, Lesotho National Tuberculosis Program, Ministry of Health, Maseru, Lesotho.
Mabatho MoleteDistrict Health Management Team, Butha Buthe, Ministry of Health, Lesotho National Tuberculosis Program, Ministry of Health, Maseru, Lesotho.
Retselisitsoe RatikoaneDistrict Health Management Team, Butha Buthe, Ministry of Health, Lesotho National Tuberculosis Program, Ministry of Health, Maseru, Lesotho.
Modupe OgunrombiDepartment of Clinical Pharmacology, Sefako Makgatho Health Sciences University, Pretoria, Gauteng, South Africa.
Olawande DaramolaDepartment of Informatics, Faculty of Engineering, Built Environment & IT, University of Pretoria, Pretoria, Gauteng, South Africa.
Bonheur DounebaineAfrica CDC, Public Health Workforce Division, Addis Ababa, Ethiopia.
Sara Adel AbbasCentral Agency for Public Mobilization and Statistics, Cairo, Egypt.
Peter S NyasuluDivision of Epidemiology and Biostatistics, Faculty of Medicine, and Health Sciences, Stellenbosch University, Cape Town, South Africa. pnyasulu@sun.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn a normal regression analysis for determinants of tuberculosis (TB) outcomes, assumptions that the sample is homogenous are made. However, the model does not account for the overall effect of unobserved or unmeasured covariates. Frailty may exacerbate the effects of TB on patients and raise their risk of death in Lesotho. This study aims to quantify the amount of heterogeneity that exists at the facility level, and to ascertain the determinants of TB mortality across all the catchment areas in Lesotho.

methodsThis was a retrospective cohort of patients on TB treatment registered from January 2015 to December 2020 at twelve (12) health care facilities in the district of Butha Buthe, Lesotho. Data were collected from patient's medical records and analyzed using R and Integrated Nested Laplace Approximation (INLA). Descriptive statistics were presented using frequency tables. Differences between binary outcomes were analyzed using Pearson's X

resultsThe total number of patients included in the analysis were 1729 of which 70% were males, and about half of them were employed (54.2%). Being over 60 years (HR: 0.14, Cl: 0.02-0.94) 20-59 years (HR: 0.07, Cl: 0.01-0.41), and TB category 2 (HR 0.27, Cl 0.09-0.80) decreased the risk of dying. Miners had an increased risk of dying from TB (HR:4.13, Cl: 1.05 - 16.43). Assessing heterogeneity by varying the frailty distribution revealed interesting results. For instance, specifying frailty variance structure to follow gamma distribution resulted in estimating minimal 1.01 heterogeneity between catchment areas. The heterogeneity estimated by specifying the Gaussian distribution for the frailty term resulted in nearly 4.5 times more likely to have increased the risk of dying.

conclusionThe results from both Gamma and Gaussian demonstrate that heterogeneity affected significance of the determinants for TB mortality. The results showed that facility level was significantly likely to increase the risk of dying, indicating differences between catchment areas.

Indexed as

TuberculosisAdultAgedBayes TheoremFemaleFrailtyHealth FacilitiesHumansLesothoMaleMiddle AgedRetrospective StudiesRisk FactorsYoung AdultBayesian regression modelsHeterogeneityTB mortality

Identifiers

PMID41814200
PMCPMC13088415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.